Kwak SH, Han KA, Kim ES, Choi SH, et al. Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trial. Diabetes Obes Metab 2024 Jul 26. doi: 10.1111/dom.15738.
PMID: 39054871